Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis

Veterinary Immunology and Immunopathology

Volumn 129, Issue 3-4, 2009, Pages 221-230

  Loftus, John P ^a   Johnson, Philip J ^b   Belknap, James K ^c   Pettigrew, Amanda ^c   Black, Samuel J ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Inflammation; Laminitis; Metalloproteinase

Indexed keywords

FURIN; GELATINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HOOF AND CLAW; HORSE DISEASE; LAMINITIS; LEUKOCYTE; MALE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SOFT TISSUE; ZYMOGRAPHY;

ANIMALS; CARBOHYDRATES; FEMALE; FOOT DISEASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOOF AND CLAW; HORSE DISEASES; HORSES; INFLAMMATION; LEUKOCYTES; MALE; MATRIX METALLOPROTEINASES;

ANIMALIA; EQUIDAE;

EID: 64749106536     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.11.003     Document Type: Article

References (52)

1. Adair III H.S., Goble D.O., Schmidhammer J.L., and Shires G.M. Lamellar microvascular flow, measured by means of laser Doppler flowmetry, during the prodromal stages of black walnut-induced laminitis in horses. Am. J. Vet. Res. 61 (2000) 862-868
2. Bailey S.R., Baillon M.L., Rycroft A.N., Harris P.A., and Elliott J. Identification of equine cecal bacteria producing amines in an in vitro model of carbohydrate overload. Appl. Environ. Microbiol. 69 (2003) 2087-2093
3. Bailey S.R., Rycroft A., and Elliott J. Production of amines in equine cecal contents in an in vitro model of carbohydrate overload. J. Anim. Sci. 80 (2002) 2656-2662
4. Bailey S.R., Wheeler-Jones C., and Elliott J. Uptake of 5-hydroxytryptamine by equine digital vein endothelial cells: inhibition by amines found in the equine caecum. Equine Vet. J. 35 (2003) 164-169
5. Bassi D.E., Lopez De Cicco R., Cenna J., Litwin S., Cukierman E., and Klein-Szanto A.J. PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression. Cancer Res. 65 (2005) 7310-7319
6. Baxter G.M., Laskey R.E., Tackett R.L., Moore J.N., and Allen D. In vitro reactivity of digital arteries and veins to vasoconstrictive mediators in healthy horses and in horses with early laminitis. Am. J. Vet. Res. 50 (1989) 508-517
7. Belknap J.K., Giguere S., Pettigrew A., Cochran A.M., Van Eps A.W., and Pollitt C.C. Lamellar pro-inflammatory cytokine expression patterns in laminitis at the developmental stage and at the onset of lameness: innate vs. adaptive immune response. Equine Vet. J. 39 (2007) 42-47
8. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., and Engler J.A. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4 (1993) 197-250
9. Black S.J., Lunn D.P., Yin C., Hwang M., Lenz S.D., and Belknap J.K. Leukocyte emigration in the early stages of laminitis. Vet. Immunol. Immunopathol. 109 (2006) 161-166
10. Briknarova K., Grishaev A., Banyai L., Tordai H., Patthy L., and Llinas M. The second type II module from human matrix metalloproteinase 2: structure, function and dynamics. Structure 7 (1999) 1235-1245
11. Burrage P.S., Mix K.S., and Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front. Biosci. 11 (2006) 529-543
12. Chakrabarti S., and Patel K.D. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J. Leukoc. Biol. 78 (2005) 279-288
13. Clegg P.D., Coughlan A.R., and Carter S.D. Equine TIMP-1 and TIMP-2: identification, activity and cellular sources. Equine Vet. J. 30 (1998) 416-423
14. Colles C.M., and Jeffcott L.B. Laminitis in the horse. Vet. Rec. 100 (1977) 262-264
15. Eaton S.A., Allen D., Eades S.C., and Schneider D.A. Digital Starling forces and hemodynamics during early laminitis induced by an aqueous extract of black walnut (Juglans nigra) in horses. Am. J. Vet. Res. 56 (1995) 1338-1344
16. Fini M.E., Girard M.T., and Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol. Suppl. (1992) 26-33
17. Fontaine G.L., Belknap J.K., Allen D., Moore J.N., and Kroll D.L. Expression of interleukin-1beta in the digital lamellae of horses in the prodromal stage of experimentally induced laminitis. Am. J. Vet. Res. 62 (2001) 714-720
18. French K.R., and Pollitt C.C. Equine laminitis: glucose deprivation and MMP activation induce dermo-epidermal separation in vitro. Equine Vet. J. 36 (2004) 261-266
19. French K.R., and Pollitt C.C. Equine laminitis: loss of hemidesmosomes in hoof secondary epidermal lamellae correlates to dose in an oligofructose induction model: an ultrastructural study. Equine Vet. J. 36 (2004) 230-235
20. Galey F.D., Twardock A.R., Goetz T.E., Schaeffer D.J., Hall J.O., and Beasley V.R. Gamma scintigraphic analysis of the distribution of perfusion of blood in the equine foot during black walnut (Juglans nigra)-induced laminitis. Am. J. Vet. Res. 51 (1990) 688-695
21. Galey F.D., Whiteley H.E., Goetz T.E., Kuenstler A.R., Davis C.A., and Beasley V.R. Black walnut (Juglans nigra) toxicosis: a model for equine laminitis. J. Comp. Pathol. 104 (1991) 313-326
22. Garner H.E., Coffman J.R., Hahn A.W., Hutcheson D.P., and Tumbleson M.E. Equine laminitis of alimentary origin: an experimental model. Am. J. Vet. Res. 36 (1975) 441-444
23. Hayashido Y., Urabe K., Yoshioka Y., Kitano H., Okamoto T., and Matsuya T. Participation of fibroblasts in MMP-2 binding and activation on the surface of oral squamous cell carcinoma cells. Int. J. Oncol. 22 (2003) 657-662
24. Johnson P.J., Kreeger J.M., Keeler M., Ganjam V.K., and Messer N.T. Serum markers of lamellar basement membrane degradation and lamellar histopathological changes in horses affected with laminitis. Equine Vet. J. 32 (2000) 462-468
25. Johnson P.J., Tyagi S.C., Katwa L.C., Ganjam V.K., Moore L.A., Kreeger J.M., and Messer N.T. Activation of extracellular matrix metalloproteinases in equine laminitis. Vet. Rec. 142 (1998) 392-396
26. Kuno K., Kanada N., Nakashima E., Fujiki F., Ichimura F., and Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J. Biol. Chem. 272 (1997) 556-562
27. Kyaw-Tanner M., and Pollitt C.C. Equine laminitis: increased transcription of matrix metalloproteinase-2 (MMP-2) occurs during the developmental phase. Equine Vet. J. 36 (2004) 221-225
28. Le N.T., Xue M., Castelnoble L.A., and Jackson C.J. The dual personalities of matrix metalloproteinases in inflammation. Front. Biosci. 12 (2007) 1475-1487
29. Loftus J.P., Belknap J.K., and Black S.J. Matrix metalloproteinase-9 in lamellae of black walnut extract treated horses correlates with neutrophil abundance. Vet. Immunol. Immunopathol. 113 (2006) 267-276
30. Loftus J.P., Black S.J., Pettigrew A., Abrahamsen E.J., and Belknap J.K. Early lamellar events involving endothelial activation in horses with black walnut-induced laminitis. Am. J. Vet. Res. 68 (2007) 1205-1211
31. Makowski G.S., and Ramsby M.L. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection. Clin. Chim. Acta 329 (2003) 77-81
32. Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front. Biosci. 11 (2006) 1696-1701
33. Mungall B.A., Kyaw-Tanner M., and Pollitt C.C. In vitro evidence for a bacterial pathogenesis of equine laminitis. Vet. Microbiol. 79 (2001) 209-223
34. Mungall B.A., and Pollitt C.C. Zymographic analysis of equine laminitis. Histochem. Cell Biol. 112 (1999) 467-472
35. Mungall B.A., Pollitt C.C., and Collins R. Localisation of gelatinase activity in epidermal hoof lamellae by in situ zymography. Histochem. Cell Biol. 110 (1998) 535-540
36. Pilcher B.K., Wang M., Qin X.J., Parks W.C., Senior R.M., and Welgus H.G. Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann. N. Y. Acad. Sci. 878 (1999) 12-24
37. Pollitt C.C. Basement membrane pathology: a feature of acute equine laminitis. Equine Vet. J. 28 (1996) 38-46
38. Pollitt C.C., and Daradka M. Equine laminitis basement membrane pathology: loss of type IV collagen, type VII collagen and laminin immunostaining. Equine Vet. J. Suppl. (1998) 139-144
39. Pollitt C.C., Kyaw-Tanner M., French K.R., Van Eps A.W., Hendrikz J.K., and Daradka M. Equine Laminitis. Proc. Am. Assoc. Equine Pract. 49 (2003) 103-115
40. Pollitt C.C., Pass M.A., and Pollitt S. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis. Equine Vet. J. Suppl. (1998) 119-124
41. Ravanti L., and Kahari V.M. Matrix metalloproteinases in wound repair (review). Int. J. Mol. Med. 6 (2000) 391-407
42. Sato H., Kinoshita T., Takino T., Nakayama K., and Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393 (1996) 101-104
43. Shamamian P., Pocock B.J., Schwartz J.D., Monea S., Chuang N., Whiting D., Marcus S.G., Galloway A.C., and Mignatti P. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion. Surgery 127 (2000) 142-147
44. Shamamian P., Schwartz J.D., Pocock B.J., Monea S., Whiting D., Marcus S.G., and Mignatti P. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J. Cell. Physiol. 189 (2001) 197-206
45. Sprouse R.F., Garner H.E., and Green E.M. Plasma endotoxin levels in horses subjected to carbohydrate induced laminitis. Equine Vet. J. 19 (1987) 25-28
46. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., and Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270 (1995) 5331-5338
47. Tortorella M.D., Malfait A.M., Deccico C., and Arner E. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 9 (2001) 539-552
48. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., and Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37 (2002) 375-536
49. Van Lint P., and Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev. 17 (2006) 217-223
50. Waguespack R.W., Cochran A., and Belknap J.K. Expression of the cyclooxygenase isoforms in the prodromal stage of black walnut-induced laminitis in horses. Am. J. Vet. Res. 65 (2004) 1724-1729
51. Waguespack R.W., Kemppainen R.J., Cochran A., Lin H.C., and Belknap J.K. Increased expression of MAIL, a cytokine-associated nuclear protein, in the prodromal stage of black walnut-induced laminitis. Equine Vet. J. 36 (2004) 285-291
52. Werners A.H., Bull S., Vendrig J.C., Smyth T., Bosch R.R., Fink-Gremmels J., and Bryant C.E. Genotyping of toll-like receptor 4, myeloid differentiation factor 2 and CD-14 in the horse: an investigation into the influence of genetic polymorphisms on the LPS induced TNF-alpha response in equine whole blood. Vet. Immunol. Immunopathol. 111 (2006) 165-173